Abstract

Alterations in gut microbiota and short chain fatty acids (SCFA) have been reported in autism spectrum disorder (ASD). We analysed the gut microbiota and fecal SCFA in Tunisian autistic children from 4 to 10 years, and results were compared to those obtained from a group of siblings (SIB) and children from the general population (GP). ASD patients presented different gut microbiota profiles compared to SIB and GP, with differences in the levels of Bifidobacterium and Collinsella occurring in younger children (4–7 years) and that tend to be attenuated at older ages (8–10 years). The lower abundance of Bifidobacterium is the key feature of the microbiota composition associated with severe autism. ASD patients presented significantly higher levels of propionic and valeric acids than GP at 4–7 years, but these differences disappeared at 8–10 years. To the best of our knowledge, this is the first study on the gut microbiota profile of Tunisian autistic children using a metataxonomic approach. This exploratory study reveals more pronounced gut microbiota alterations at early than at advanced ages in ASD. Although we did not account for multiple testing, our findings suggest that early interventions might mitigate gut disorders and cognitive and neurodevelopment impairment associated to ASD.

Details

Title
Age and severity-dependent gut microbiota alterations in Tunisian children with autism spectrum disorder
Author
Chamtouri, Mariem 1 ; Gaddour, Naoufel 2 ; Merghni, Abderrahmen 3 ; Mastouri, Maha 4 ; Arboleya, Silvia 5 ; de los Reyes-Gavilán, Clara G. 5 

 Instituto de Productos Lácteos de Asturias (IPLA-CSIC), Department of Microbiology and Biochemistry of Dairy Products, Villaviciosa, Spain (GRID:grid.419120.f) (ISNI:0000 0004 0388 6652); University of Monastir, Laboratory of Transmissible Diseases and Biologically Active Substances LR99ES27, Faculty of Pharmacy, Monastir, Tunisia (GRID:grid.411838.7) (ISNI:0000 0004 0593 5040) 
 Monastir University Hospital, Unit of Child Psychiatry, Monastir, Tunisia (GRID:grid.411838.7) (ISNI:0000 0004 0593 5040) 
 University of Tunis El Manar, Laboratory of Antimicrobial Resistance LR99ES09, Faculty of Medicine of Tunis, Tunis, Tunisia (GRID:grid.12574.35) (ISNI:0000000122959819) 
 University of Monastir, Laboratory of Transmissible Diseases and Biologically Active Substances LR99ES27, Faculty of Pharmacy, Monastir, Tunisia (GRID:grid.411838.7) (ISNI:0000 0004 0593 5040) 
 Instituto de Productos Lácteos de Asturias (IPLA-CSIC), Department of Microbiology and Biochemistry of Dairy Products, Villaviciosa, Spain (GRID:grid.419120.f) (ISNI:0000 0004 0388 6652); Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Diet, Microbiota, and Health Group, Oviedo, Spain (GRID:grid.511562.4) 
Pages
18218
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2881549459
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.